87 percent of Medicare Advantage members enrolled in plans rated 4.0 stars or higher, demonstrating our commitment to providing high-quality plans to our Medicare members
Aetna’s Medicare Advantage Prescription Drug (MAPD) plans have once again received higher than average ratings from the Centers for Medicare and Medicaid Services (CMS) in the annual Star Ratings, released on October 11. For 2018, Aetna’s MAPD plans earned an overall weighted average rating of 4.0 out of 5.0 stars, with 87 percent of Medicare members enrolled in plans rated 4.0 or higher — the highest percentage among publicly traded companies.* ... |